Diagnosis and treatment of pancreatic exocrine insufficiency

JE Dominguez-Muñoz - Current opinion in gastroenterology, 2018 - journals.lww.com
Awareness of PEI in different clinical conditions is required. Nutritional advice and
appropriate PERT are mandatory to reduce the morbidity and mortality associated with PEI …

Pancreatic enzyme replacement therapy in pancreatic cancer

R Pezzilli, R Caccialanza, G Capurso, O Brunetti… - Cancers, 2020 - mdpi.com
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global
cancer deaths in industrialised countries. More than 80% of patients suffer from significant …

Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS)

L Gianotti, MG Besselink, M Sandini, T Hackert… - Surgery, 2018 - Elsevier
Background The optimal nutritional therapy in the field of pancreatic surgery is still debated.
Methods An international panel of recognized pancreatic surgeons and pancreatologists …

Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study

KJ Roberts, CA Bannister, H Schrem - Pancreatology, 2019 - Elsevier
Background Pancreatic exocrine insufficiency (PEI) and malnutrition are prevalent among
patients with pancreatic adenocarcinoma. Pancreatic enzyme replacement therapy (PERT) …

Pancreatic exocrine insufficiency as a complication of gastrointestinal surgery and the impact of pancreatic enzyme replacement therapy

A Chaudhary, JE Domínguez-Muñoz, P Layer… - Digestive …, 2020 - karger.com
Background: Pancreatic exocrine insufficiency (PEI) is characterized by inadequate
production, insufficient secretion, and/or inactivation of pancreatic enzymes, resulting in …

Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment

R De Luca, L Gianotti, P Pedrazzoli, O Brunetti… - European Journal of …, 2023 - Elsevier
Pancreatic cancer (PC) is an aggressive disease, with a growing incidence, and a poor
prognosis. Neoadjuvant treatments in PC are highly recommended in borderline resectable …

The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent

CE Forsmark, G Tang, H Xu, M Tuft… - Alimentary …, 2020 - Wiley Online Library
Background Patients with chronic pancreatitis or pancreatic cancer commonly develop
exocrine pancreatic insufficiency, and may not be adequately treated with pancreatic …

[HTML][HTML] Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer

G Roeyen, F Berrevoet, I Borbath, K Geboes, M Peeters… - ESMO open, 2022 - Elsevier
Highlights•PEI is a common condition in PC patients and should be actively looked for in PC
patients and treated with PERT.•In resected and borderline resectable patients PERT should …

[HTML][HTML] Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency

P Layer, N Kashirskaya, N Gubergrits - World Journal of …, 2019 - ncbi.nlm.nih.gov
The objective of this study was to analyze the current evidence for the use of pancreatic
enzyme replacement therapy (PERT) in affecting survival and quality of life in patients with …

Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study

L Scholten, AEJ Latenstein, C van Eijck, J Erdmann… - Surgery, 2019 - Elsevier
Background The threshold to perform total pancreatectomy is rather high, predominantly
because of concerns for long-term consequences of brittle diabetes on patients' quality of …